惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Jina AI
Jina AI
月光博客
月光博客
F
Fortinet All Blogs
Stack Overflow Blog
Stack Overflow Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
V
Visual Studio Blog
小众软件
小众软件
博客园 - 三生石上(FineUI控件)
博客园 - 司徒正美
P
Proofpoint News Feed
酷 壳 – CoolShell
酷 壳 – CoolShell
M
MIT News - Artificial intelligence
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
B
Blog RSS Feed
Apple Machine Learning Research
Apple Machine Learning Research
S
SegmentFault 最新的问题
博客园_首页
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
J
Java Code Geeks
L
LangChain Blog
博客园 - 聂微东
G
Google Developers Blog
博客园 - Franky

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health
Lowering Healthcare Costs Without A Disastrous Government...
Steve Forbes · 2026-04-08 · via Forbes - Healthcare

Healthcare Stethoscope

getty

The relentlessly rising cost of healthcare will be a big issue in the fall elections. The cure is free markets, and, to that end, unshackling Health Savings Accounts (HSAs) would be a huge step forward.

In free markets customers call the shots, and if a seller doesn’t meet buyers’ wants or needs, the seller fails. However, that basic fact isn’t true in healthcare. We don’t yet have a single-payer, government-run system—so beloved by the left—which suffocates innovation and controls costs through rationing via long waits for service. But we also don’t have genuine free markets either. Currently, the customer, in this case the patient, doesn’t control the purse strings; third parties—large insurers, hospitals and Medicare and Medicaid—dominate the market.

Without the discipline of competition, costs soar. To control costs, government regulations and mandates grow like kudzu. Insurance companies second-guess doctors and all too often deny coverage. Shockingly, one-fifth of in-network claims are denied; one-third of out-of-network claims are rejected. Reimbursements by Medicare and Medicaid don’t cover actual expenses. The Medicaid system in particular encourages providers to go for volume with quick, indifferent assembly-line care. Fraud is rampant.

Certain solutions proffered by politicians destructively deal with symptoms, such as imposing price controls on drugs, not the underlying cause, which is the lack of free markets. With coverage increasingly costly, employers have resorted to higher deductibles and higher co-pays on plans for employees. Other employers have dumped their plans and opted to have workers get coverage on the heavily-subsidized Obamacare exchanges.

HSAs are crucial to getting sanity into healthcare. Contributions are tax-deductible, assets grow tax-free and money used from these accounts for allowable medical expenses isn’t taxable. Around 60 million people are covered by HSAs.

While the Big Beautiful Bill passed last summer made positive changes, HSAs are still hemmed in by regulations that prevent them from being the powerhouse vehicle for patient-control of healthcare dollars. HSAs should be available to all individuals, whether or not they’re covered by a high-deductible insurance plan or are on Medicare. Contribution limits—now $4,400 for individuals and $8,750 for families—should be tripled. After all, typical family plans now cost $27,000. Any remaining barriers for buying individual health insurance plans by using HSA funds should be abolished.

Other free-market changes include removing restrictions on catastrophic health insurance policies, which have low premiums and provide coverage for big medical expenses. People should also have the freedom to buy cheap, short-term policies that avoid certain Obamacare mandates that make insurance unnecessarily expensive. Currently, such plans expire within a year and, depending on regulations, can be renewed annually for up to three years. Goodness gracious, make these permanent by law and remove the time limits altogether. Everyone should have the choice to buy their own insurance.

Competition works. In Singapore the taxes people pay for healthcare coverage don’t go to the government, but to their own accounts. They choose their policies and the hospitals they use. Providers compete for their business. The result: Healthcare expenses in Singapore come to about 5% of GDP vs. 18% in the U.S., and longevity is higher in Singapore than in the U.S.